Posted ineHealth Technology News
Canadian biotech venture capital firm Lumira starts hedge fund to target oversold public companies
Canadian biotech venture capital firm Lumira starts hedge fund to target oversold public companies Lumira Ventures, one of Canada's top investors in private health sciences ... on established biotherapeutics and…